Pet Dogs Bring Both Joy and Worry to Displaced Gaza Teenager 

Displaced Palestinian teenager Hassan Abu Saman holds his dog on a beach, amid the ongoing conflict between Israel and the Palestinian group Hamas, in Rafah, in the southern Gaza Strip, February 20, 2024. (Reuters)
Displaced Palestinian teenager Hassan Abu Saman holds his dog on a beach, amid the ongoing conflict between Israel and the Palestinian group Hamas, in Rafah, in the southern Gaza Strip, February 20, 2024. (Reuters)
TT

Pet Dogs Bring Both Joy and Worry to Displaced Gaza Teenager 

Displaced Palestinian teenager Hassan Abu Saman holds his dog on a beach, amid the ongoing conflict between Israel and the Palestinian group Hamas, in Rafah, in the southern Gaza Strip, February 20, 2024. (Reuters)
Displaced Palestinian teenager Hassan Abu Saman holds his dog on a beach, amid the ongoing conflict between Israel and the Palestinian group Hamas, in Rafah, in the southern Gaza Strip, February 20, 2024. (Reuters)

Keeping three dogs while living in a tent on a beach in Gaza complicates an already difficult situation, but the smile on teenager Hassan Abu Saman's face when he pets the animals shows that it's worth the trouble for him.

A passionate dog lover since childhood, he had 16 of them before the Israel-Hamas war that has devastated the Gaza Strip, but managed to take just three of them, Mofaz, Lucy and Dahab, when he fled his home in Al-Nuseirat refugee camp in central Gaza.

"When things settled, I was able to secure a car to go and get the rest, but when I got back, I did not find any of them, they were lost. I went back a second time to look for them and found the house bombed," said Abu Saman, 17.

He is one of the estimated 1.5 million Palestinians crammed into Rafah in southern Gaza, close to the boundary with Egypt, to escape from Israel's military onslaught -- although Israel has said it was planning a ground offensive there too.

Abu Saman is living in a sprawling tent camp in a beach area on the outskirts of Rafah, along with family members and the three dogs, who follow him everywhere he goes. They are popular with camp children who take turns stroking them.

Abu Saman referred to the dogs as "my friends from another kind" and spoke about them as he would about people.

"He has been feeling so down because of the war," he said of Mofaz, the largest of the three.

Finding enough food was a problem for dogs as well as humans, and Abu Saman said Lucy and Dahab had lost weight because they usually ate a special kind of dog food that was no longer available.

The future was uncertain for the teenager, his family and his beloved pets.

"If we were to return, the house is flattened. He does not have a house or anything," he said, referring to Mofaz, who he was stroking while talking.

The war was triggered by Hamas militants who attacked southern Israel on Oct. 7, killing 1,200 people and taking 253 hostage, according to Israel.

Vowing to destroy Hamas, Israel has responded with an air and ground assault on Gaza that has killed more than 29,000 people, according to local health officials. It has also displaced most of the population of 2.3 million, caused widespread hunger and reduced much of the territory to rubble.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”